ArticleAnnals of biomedical engineering2025
Towards the Intravascular Delivery of 3D-printed Leached SMP for Endovascular Treatment of Intracranial Aneurysm.
Article in Annals of biomedical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In-Vitro Evaluations of Shape Memory Polymer Scaffolds With Tunable Architecture for the Endovascular Embolization of Unruptured Intracranial Aneurysms.Journal of biomechanical engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeIntracranial aneurysms (ICAs) pose a serious clinical risk due to their potential for rupture, leading to subarachnoid hemorrhage, high morbidity, and mortality. This study aims to develop a proof-of-concept device for the targeted delivery of shape memory polymers (SMPs)-based embolic devices to improve aneurysm occlusion and reduce recurrence.
methodsA novel system was designed combining a radial compression fixture and an electronic device for Joule heating and electrolytic detachment (ED). Three SMP geometries (5, 6.5 mm spherical, and patient-specific) were evaluated for the shape recovery and thermal responses. In-vitro testing was performed using 6.5 mm and patient-specific geometries in PDMS aneurysm phantoms under physiological relevant conditions utilizing ovine blood.
resultsControlled activation of the SMPs at currents of 400 mA achieved reproducible shape recovery ratios (SRRs) up to 75.71%, with detachment occurring at < 100 mA. Surface temperatures remained below 45 °C. In-vitro deployment resulted in aneurysm sac occlusion of 90.32% (patient-specific) and 94.12% (idealized), without evidence of thermal damage or gas accumulation. Flow visualization confirmed reduced bubble entry into the aneurysm sac post-deployment.
conclusionThis study demonstrates the feasibility of a targeted delivery system for patient-specific ICA treatment using SMPs. While further refinement and in-vivo validation are required, these findings highlight the potential of SMPs as durable embolization devices capable of conforming to complex aneurysm geometries and providing more effective occlusion compared to current methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.